Offerings // XTL BIOPHARMACEUTICALS LTD

XTLB offering history

Every offering-related filing in XTL BIOPHARMACEUTICALS LTD’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 546 filings back to Nov 17, 2004.

Last executed offering
Feb 22, 2017
424B5 — priced deal (shares or notes)
Last registration (announced)
Feb 28, 2018
F-1/A — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Jun 9, 2021424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 7, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 7, 2018424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 6, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 28, 2018F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Feb 1, 2018F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Feb 22, 2017424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 8, 2016F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Dec 31, 2015F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Apr 1, 2015424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 26, 2014424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 26, 2014FWP →MARKETINGFree-writing prospectus — offering being marketed
Apr 4, 2014F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Apr 4, 2014EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 2, 2014F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Mar 5, 2014F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Oct 4, 2012424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 19, 2010424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 11, 2008EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 5, 2008F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Aug 15, 2008F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Nov 20, 2007F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Nov 20, 2007EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 13, 2007F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Oct 30, 2007F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Mar 29, 2007424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 28, 2007EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 23, 2007F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
May 23, 2006424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 22, 2006EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 21, 2006F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jul 7, 2005RW →WITHDRAWNRegistration withdrawn
XTLB offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full XTLB workspace →
XTLB offering FAQ

When did XTLB last execute an offering?

Per SEC filings, XTL BIOPHARMACEUTICALS LTD's most recent priced offering document is a 424B5 filed 2017-02-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did XTLB last announce or register an offering?

The most recent registration is a F-1/A filed 2018-02-28. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.